Daily rhythms in spontaneous and diazepam-induced anxiolysis in Syrian hamsters

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 4, 1996, Pages 651-656

  Yannielli, Paola C ^a   Kanterewicz, Beatriz I ^a   Cardinali, Daniel P ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anxiolysis; Diazepam; Diurnal rhythmus; Exploratory behavior; Time dependent effects

Indexed keywords

DIAZEPAM; ETHYL BETA CARBOLINE; FLUMAZENIL; FLUNITRAZEPAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HAMSTER; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030219692     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02106-X     Document Type: Article

References (35)

1. 1. Andrews, N.; File, S. E. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze. Eur. J. Pharmacol. 190:229-234; 1990.
2. 2. Baldwin, A.; File, S. E. The elevated plus-maze test of anxiety: Further behavioral validation. Pyschopharmacology 89:59-62; 1986.
3. 3. Biggio, G.; Concas, A.; Corda, M. G.; Giorgi, O.; Sanna, E.; Serra, M. Gabaergic and dopaminergic transmission in the rat cerebral cortex: Effect of stress, anxiolytic and anxiogenic drugs. Pharmacol. Ther. 48:121-142; 1990.
4. 4. Bitran, D.; Purdy, R.; Kellogg, C. K. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABA A receptor function. Pharmacol. Biochem. Behav. 45:423-428; 1993.
5. 5. Blumstein, L. K.; Crawley, J. N. Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 18:37-40; 1983.
6. 6. Chopin, P.; Briley, M. Animal models of anxiety: The effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol. Sci. 8:383-387; 1987.
7. 7. Chopin, P.; Briley, M. The benzodiazepine antagonist flumazenil blocks the effects of CCK-receptor agonists and antagonists in the elevated plus-maze. Psychopharmacology 110:409-414; 1993.
8. 8. Christmas, A. J.; Maxwell, D. R. A comparison of the effects of some benzodiazepines and other drugs on aggressive and exploratory behavior in mice and rats. Neuropharmacology 9:17-29; 1970.
9. 9. Costa, E.; Corda, M. G.; Guidotti, A. On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives. Neuropharmacology 22:1481-1492; 1983.
10. 10. Costall, B.; Jones, B. J.; Kelly, M. E.; Naylor, R. J.; Tomkins, D. M. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:777-785; 1989.
11. 11. Crawley, J. N.; Glowa, J.; Majewska, M. D.; Paul, S. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398:382-385; 1986.
12. 12. De Robertis, E.; Pena, C.; Paladini, A. C.; Medina, J. New developments on the search for the endogenous ligand(s) of central benzodiazepine receptors. Neurochem. Int. 13:1-11; 1988.
13. 13. Eidman, D. S.; Benedito, M. A.; Leite, J. R. Daily changes in pentylenetetrazol-induced convulsions and open field behavior in rats. Physiol. Behav. 47:853-856; 1990.
14. 14. File, S. E.; Hyde, J. R. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol. Biochem. Behav. 11: 65-69; 1979.
15. 15. File, S. E.; Pellow, S. Intrinsic actions of the benzodiazepine receptor antagonist Ro 151788. Psychopharmacology 88:1-11; 1986.
16. 16. File, S. E.; Zangrossi, H.; Andrews, N. Social interaction and elevated plus-maze test: Changes in release and uptake of 5-HT and GABA. Neuropharmacology 32:217-221; 1993.
17. 17. File, S. E.; Zangrossi, H.; Viana, M.; Graeff, F. Trial 2 in the elevated plus maze: A different form of fear? Psychopharmacology 11:491-494; 1993.
18. 18. Golombek, D. A.; Escolar, E.; Burin, L.; De Brito Sanchez, M. G.; Cardinali, D. P. Time dependent melatonin analgesia in mice: Inhibition by opiate or benzodiazepine antagonism. Eur. J. Pharmacol. 194:25-30; 1991.
19. 19. Golombek, D. A.; Escolar, E.; Cardinali, D. P. Melatonin-induced depression of locomotor activity in hamsters: Time-dependency and inhibition by central type benzodiazepine antagonist Ro-151788. Physiol. Behav. 49:1091-1098; 1991.
20. 20. Golombek, D. A.; Fernandez Duque, D.; De Brito Sanchez, M. G.; Cardinali, D. P. Time-dependent anticonvulsant activity of melatonin in hamsters. Eur. J. Pharmacol. 210:253-258; 1992.
21. 21. Golombek, D. A.; Martini, M.; Cardinali, D. P. Melatonin as an anxiolytic in rats: Time dependence and interaction with the central GABAergic system. Eur. J. Pharmacol. 237:231-236; 1993.
22. 22. Guinjoan, S. M.; Golombek, D. A.; Cardinali, D. P. Time dependent anesthetic and anticonvulsant activities of alphaxalone in Syrian hamsters. Life Sci. 51:2089-2095; 1992.
23. 23. Haefely, W. Benzodiazepine interactions with GABA receptors. Neurosci. Lett. 47:201-206; 1984.
24. 24. Handley, S. L.; McBlane, J. W. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J. Pharmacol. Toxicol. Methods 29:129-138; 1993.
25. 25. Kanterewicz, B. I.; Golombek, D. A.; Rosenstein, R. E.; Cardinali, D. P. Diurnal changes of GABA turnover rate in brain and pineal gland of Syrian hamsters. Brain Res. Bull. 31:661-666; 1993.
26. 26. Klein, D. C.; Moore, R. Y.; Reppert, S. M. Suprachiasmatic nucleus: The mind's clock. Oxford; Oxford Science; 1992.
27. 27. Melchior, C. L.; Ritzmann, R. F. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol. Biochem. Behav. 47:437-441; 1994.
28. 28. Moore, R. Y. Organization and function of a CNS circadian oscillator: The suprachiasmatic nucleus. Fed. Proc. 42:2783-2789; 1983.
29. 29. Moore, R. Y.; Speh, J. C. GABA is the principal neurotransmitter of the circadian system. Neurosci. Lett. 150:112-116; 1993.
30. 30. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open: closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
31. 31. Pellow, S.; File, S. E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:525-529; 1986.
32. 32. Rosenstein, R. E.; Cardinali, D. P. Central gabaergic mechanisms as targets for melatonin activity in brain. Neurochem. Int. 17:373-379; 1990.
33. 33. Ticku, M. Benzodiazepine-GABA receptor-ionophore complex. Neuropharmacology 22:1459-1469; 1983.
34. 34. Wirz-Justice, A. Circadian rhythms in mammalian neurotransmitter receptors. Prog. Neurobiol. 29:219-259; 1987.
35. 35. Zorumsky, C. F.; Isemberg, K. E. Insights into the structure and function of GABA-BDZ receptors: Ion-channels and psychiatry. Am. J. Psychiatry 148:162-173; 1991.